38 results on '"Spangenberg C"'
Search Results
2. Process analysis and economics of drinking water production from coastal aquifers containing chromophoric dissolved organic matter and bromide using nanofiltration and ozonation
- Author
-
Sobhani, R., McVicker, R., Spangenberg, C., and Rosso, D.
- Published
- 2012
- Full Text
- View/download PDF
3. Location and Restoration of Function after Cerebellar Tumor Removal—A Longitudinal Study of Children and Adolescents
- Author
-
Küper, M., Döring, K., Spangenberg, C., Konczak, J., Gizewski, E. R., Schoch, B., and Timmann, D.
- Published
- 2013
- Full Text
- View/download PDF
4. TRANSCRIPTIONAL REGULATION OF THE MMTV PROMOTER: SP60
- Author
-
Beato, M., Chávez, S., DiCroce, L., Eisfeld, K., Spangenberg, C., Truss, M., and Venditti, P.
- Published
- 1996
5. hOAT1, a novel organic anion transporter in kidney
- Author
-
Prawitt, D., Bahn, A., Enklaar, T., Fees, S., Hauser, H., Brixel, L., Spangenberg , C., Quondamatteo, F., Hillemann, A., Herken, R., Burckhardt, G., and Zabel, B.U.
- Subjects
Human genetics -- Research ,Anion exchangers (Biology) -- Genetic aspects ,Kidneys -- Genetic aspects ,Biological sciences - Published
- 2001
6. Further characterization of MTR1, a novel gene from the BWS-WT2 critical region on chromosome 11p15.5 and its murine homolog
- Author
-
Prawitt, D., Enklaar, T., Brixel, L., Thesker, M., Langer, A., Spangenberg, C., Fees, S., Higgins, M., Weissman, B., and Zabel, B.U.
- Subjects
Human genetics -- Research ,Beckwith-Wiedemann syndrome -- Genetic aspects ,Biological sciences - Published
- 2000
7. Zur Stellungnahme des Deutschen Ethikrats „Embryospende, Embryoadoption und elterliche Verantwortung“.
- Author
-
Spangenberg, C.
- Published
- 2018
- Full Text
- View/download PDF
8. Location and Restoration of Function after Cerebellar Tumor Removal—A Longitudinal Study of Children and Adolescents
- Author
-
Küper, M., primary, Döring, K., additional, Spangenberg, C., additional, Konczak, J., additional, Gizewski, E. R., additional, Schoch, B., additional, and Timmann, D., additional
- Published
- 2012
- Full Text
- View/download PDF
9. Recovery of stance and gait ataxia in children with acute surgical lesions
- Author
-
Spangenberg, C, primary, Döring, K, additional, Hogan, A, additional, Gizewski, E, additional, Konczak, J, additional, Schoch, B, additional, and Timmann, D, additional
- Published
- 2009
- Full Text
- View/download PDF
10. 37. Recovery of motor symptoms in children after surgical lesions of the cerebellum: A prospective study
- Author
-
Döring, K., primary, Spangenberg, C., additional, Hogan, A., additional, Gizewski, E.R., additional, Konczak, J., additional, Schoch, B., additional, and Timmann, D., additional
- Published
- 2009
- Full Text
- View/download PDF
11. Recovery of motor symptoms in children after surgical lesions of the cerebellum: A prospective study
- Author
-
Döring, K, primary, Spangenberg, C, additional, Hogan, A, additional, Gizewski, ER, additional, Konczak, J, additional, Schoch, B, additional, and Timmann, D, additional
- Published
- 2008
- Full Text
- View/download PDF
12. Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models
- Author
-
Hengstler, J., primary, Bockamp, E., additional, Hermes, M., additional, Brulport, M., additional, Bauer, A., additional, Schormann, W., additional, Schiffer, I., additional, Hausherr, C., additional, Eshkind, L., additional, Antunes, C., additional, Franzen, A., additional, Krishnamurthi, K., additional, Lausch, E., additional, Lessig/snm, R., additional, >, Bentham Science Publisher, additional, Chakrabarti, T., additional, Prawitt, D., additional, Zabel, B., additional, and Spangenberg, C., additional
- Published
- 2006
- Full Text
- View/download PDF
13. 4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models
- Author
-
Eger, K., primary, Hermes, M., additional, Uhlemann, K., additional, Rodewald, S., additional, Ortwein, J., additional, Brulport, M., additional, Bauer, A.W., additional, Schormann, W., additional, Lupatsch, F., additional, Schiffer, I.B., additional, Heimerdinger, C.K., additional, Gebhard, S., additional, Spangenberg, C., additional, Prawitt, D., additional, Trost, T., additional, Zabel, B., additional, Sauer, C., additional, Tanner, B., additional, Kolbl, H., additional, Krugel, U., additional, Franke, H., additional, Illes, P., additional, Madaj-Sterba, P., additional, Bockamp, E.O., additional, Beckers, T., additional, and Hengstler, J.G., additional
- Published
- 2004
- Full Text
- View/download PDF
14. RNAi knock-down mice: an emerging technology for post-genomic functional genetics
- Author
-
Prawitt, D., primary, Brixel, L., additional, Spangenberg, C., additional, Eshkind, L., additional, Heck, R., additional, Oesch, F., additional, Zabel, B., additional, and Bockamp, E., additional
- Published
- 2004
- Full Text
- View/download PDF
15. INTEGRATING DISSIMILAR TREATMENT PLANTS INTO A REGIONAL RECYCLED WATER SYSTEM
- Author
-
Malloy, S., primary, Spangenberg, C., additional, Correa, G., additional, and Willey, B., additional
- Published
- 2004
- Full Text
- View/download PDF
16. Comparison of type IV-pilin genes of Pseudomonas aeruginosa of various habitats has uncovered a novel unusual sequence FEMS microbiology letters 126 (1995) 265–274
- Author
-
Spangenberg, C, primary
- Published
- 1995
- Full Text
- View/download PDF
17. Comparison of type IV-pilin genes ofPseudomonas aeruginosaof various habitats has uncovered a novel unusual sequence
- Author
-
Spangenberg, C., primary, Fislagea, R., additional, Sierralta, W., additional, Tümmler, B., additional, and Römling, U., additional
- Published
- 1995
- Full Text
- View/download PDF
18. Selecting membranes for removing NOM and DBP precursors
- Author
-
Spangenberg, C [Irvine Ranch Water District, CA (United States)]
- Published
- 1994
19. Holliday junction affinity of the base excision repair factor Endo III contributes to cholera toxin phage integration.
- Author
-
Bischerour J, Spangenberg C, and Barre FX
- Subjects
- Catalysis, DNA metabolism, Deoxyribonuclease (Pyrimidine Dimer) metabolism, Escherichia coli genetics, Escherichia coli Proteins metabolism, Gene Library, Genome, Glycosylation, Lysogeny, Models, Genetic, Mutagenesis, Mutation, Oligonucleotides genetics, Open Reading Frames, Recombinases metabolism, Recombination, Genetic, Bacteriophages metabolism, Cholera Toxin metabolism, DNA Repair, DNA, Cruciform, Deoxyribonuclease (Pyrimidine Dimer) genetics, Escherichia coli Proteins genetics, Vibrio cholerae metabolism
- Abstract
Toxigenic conversion of Vibrio cholerae bacteria results from the integration of a filamentous phage, CTX phage. Integration is driven by the bacterial Xer recombinases, which catalyse the exchange of a single pair of strands between the phage single-stranded DNA and the host double-stranded DNA genomes; replication is thought to convert the resulting pseudo-Holliday junction (HJ) intermediate into the final recombination product. The natural tendency of the Xer recombinases to recycle HJ intermediates back into substrate should thwart this integration strategy, which prompted a search for additional co-factors aiding directionality of the process. Here, we show that Endo III, a ubiquitous base excision repair enzyme, facilitates CTX phage-integration in vivo. In vitro, we show that it prevents futile Xer recombination cycles by impeding new rounds of strand exchanges once the pseudo-HJ is formed. We further demonstrate that this activity relies on the unexpected ability of Endo III to bind to HJs even in the absence of the recombinases. These results explain how tandem copies of the phage genome can be created, which is crucial for subsequent virion production.
- Published
- 2012
- Full Text
- View/download PDF
20. Dephosphorylation of p-ERK1/2 in relation to tumor remission after HER-2 and Raf1 blocking therapy in a conditional mouse tumor model.
- Author
-
Hausherr CK, Schiffer IB, Gebhard S, Banić A, Tanner B, Kolbl H, Thoenes E, Beckers T, Spangenberg C, Prawitt D, Trost T, Zabel B, Oesch F, Hermes M, and Hengstler JG
- Subjects
- Animals, Blotting, Western, Down-Regulation, Gene Expression Regulation, Neoplastic, Humans, Male, Mice, Mice, Nude, NIH 3T3 Cells, Neoplasms, Experimental genetics, Phosphorylation, Proto-Oncogene Proteins c-raf metabolism, Receptor, ErbB-2 metabolism, Remission Induction, Signal Transduction, Transfection, Disease Models, Animal, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 metabolism, Neoplasms, Experimental metabolism, Neoplasms, Experimental prevention & control, Proto-Oncogene Proteins c-raf antagonists & inhibitors, Receptor, ErbB-2 antagonists & inhibitors, Tetracyclines pharmacology
- Abstract
Several studies have shown that HER-2/neu (erbB-2) blocking therapy strategies can cause tumor remission. However, the responsible molecular mechanisms are not yet known. Both ERK1/2 and Akt/PKB are critical for HER-2-mediated signal transduction. Therefore, we used a mouse tumor model that allows downregulation of HER-2 in tumor tissue by administration of anhydrotetracycline (ATc). Switching-off HER-2 caused a rapid tumor remission by more than 95% within 7 d of ATc administration compared to the volume before switching-off HER-2. Interestingly, HER-2 downregulation caused a dephosphorylation of p-ERK1/2 by more than 80% already before tumor remission occurred. Levels of total ERK protein were not influenced. In contrast, dephosphorylation of p-Akt occurred later, when the tumor was already in remission. These data suggest that in our HER-2 tumor model dephosphorylation of p-ERK1/2 may be more critical for tumor remission than dephosphorylation of p-Akt. To test this hypothesis we used a second mouse tumor model that allows ATc controlled expression of BXB-Raf1 because the latter constitutively signals to ERK1/2, but cannot activate Akt/PKB. As expected, downregulation of BXB-Raf1 in tumor tissue caused a strong dephosphorylation of p-ERK1/2, but did not decrease levels of p-Akt. Interestingly, tumor remission after switching-off BXB-Raf1 was similarly efficient as the effect of HER-2 downregulation, despite the lack of p-Akt dephosphorylation. In conclusion, two lines of evidence strongly suggest that dephosphorylation of p-ERK1/2 and not that of p-Akt is critical for the rapid tumor remission after downregulation of HER-2 or BXB-Raf1 in our tumor model: (i) dephosphorylation of p-ERK1/2 but not that of p-Akt precedes tumor remission after switching-off HER-2 and (ii) downregulation of BXB-Raf1 leads to a similarly efficient tumor remission as downregulation of HER-2, although no p-Akt dephosphorylation was observed after switching-off BXB-Raf1., ((c) 2006 Wiley-Liss, Inc.)
- Published
- 2006
- Full Text
- View/download PDF
21. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
- Author
-
Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA, Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M, Sahin U, Türeci O, Koelbl H, Hengstler JG, and Zabel BU
- Subjects
- Breast Neoplasms genetics, Breast Neoplasms metabolism, Cell Line, Tumor, Cell Survival physiology, Gene Expression Regulation, Neoplastic, Humans, Integrin alpha5 biosynthesis, Integrin alpha5 genetics, Integrin alpha5beta1 genetics, Integrin beta1 biosynthesis, Integrin beta1 genetics, RNA, Messenger biosynthesis, RNA, Messenger genetics, Receptor, ErbB-2 biosynthesis, Receptor, ErbB-2 genetics, Signal Transduction, Transfection, Up-Regulation, Breast Neoplasms pathology, Integrin alpha5beta1 biosynthesis, Receptor, ErbB-2 physiology
- Abstract
Oncogenic activation of the receptor tyrosine kinase ERBB2 is a key event in the development of a number of epithelial malignancies. In these tumors, high levels of ERBB2 are strongly associated with metastatic disease and poor prognosis. Paradoxically, an inherent cellular response to hypermitogenic signaling by ERBB2 and other oncogenes seems to be growth arrest, rather than proliferation. Molecular characterization of this yet undefined antiproliferative state in independent cell lines overexpressing either wild-type ERBB2 or the mutationally activated receptor unveiled a dramatic induction of the alpha5beta1 integrin fibronectin receptor. alpha5 Integrin up-regulation is mainly a transcriptional response mediated by the hypoxia-inducible transcription factors (HIF), leading to a massive increase in membrane-resident receptor molecules and enhanced fibronectin adhesiveness of the respective cells. Functionally, ERBB2-dependent ligation of fibronectin results in improved survival of mammary adenocarcinoma cells under adverse conditions, like serum withdrawal, hypoxia, and chemotherapy. HIF-1alpha is an independent predictor of poor overall survival in patients with breast cancer. In particular, HIF-1alpha overexpression correlates significantly with early local relapse and distant metastasis, a phenotype also highly characteristic of ERBB2-positive tumors. As HIF-1alpha is known to be stabilized by ERBB2 signaling under normoxic conditions, we propose that alpha5 integrin is a major effector in this regulatory circuit and may represent the molecular basis for the HIF-1alpha-dependent aggressiveness observed in ERBB2-overexpressing breast carcinomas. Hypermitogenic ERBB2 signaling and tumor hypoxia may act synergistically to favor the establishment of chemoresistant dormant micrometastatic cells frequently observed in patients with breast cancer. This new insight could be the basis for additional approaches complementing current cancer therapy.
- Published
- 2006
- Full Text
- View/download PDF
22. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.
- Author
-
Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, and Gessler M
- Subjects
- Cell Proliferation, DNA-Binding Proteins physiology, Gene Expression Profiling, Humans, Kidney Neoplasms pathology, Oligonucleotide Array Sequence Analysis, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Smad Proteins, Trans-Activators physiology, Transforming Growth Factor beta physiology, Tumor Cells, Cultured, Wilms Tumor pathology, Antineoplastic Agents pharmacology, Gene Expression Regulation, Neoplastic drug effects, Kidney Neoplasms genetics, Tretinoin pharmacology, Wilms Tumor genetics
- Abstract
Wilms tumor is one of the most frequent neoplasias in children. Our previous microarray screening in a large series of Wilms tumors revealed several candidate genes that are deregulated in advanced tumors and are part of the retinoic acid signaling pathway. To investigate whether retinoic acid could be employed as a novel therapeutic agent in these tumors, we treated cultured Wilms tumor cells with different concentrations of all-trans retinoic acid (ATRA) and assessed gene expression changes by real-time RT-PCR as well as microarray analysis. Several genes like RARRES1, RARRES3, CTGF, CKS2, CCNA2, IGFBP3, UBE2C, CCL2 or ITM2B that were previously found to be deregulated in advanced tumors exhibited opposite expression changes after ATRA treatment. In addition to enhanced retinoid signaling, the transforming growth factor-beta (TGFbeta) pathway was strongly activated by ATRA treatment of Wilms tumor cells. Both the retinoic acid and the TGFbeta pathway mediate inhibition of cell growth. These findings represent the first molecular evidence of a potential benefit from ATRA treatment in Wilms tumors.
- Published
- 2005
- Full Text
- View/download PDF
23. Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor.
- Author
-
Prawitt D, Enklaar T, Gärtner-Rupprecht B, Spangenberg C, Lausch E, Reutzel D, Fees S, Korzon M, Brozek I, Limon J, Housman DE, Pelletier J, and Zabel B
- Subjects
- Beckwith-Wiedemann Syndrome complications, Child, Humans, Wilms Tumor complications, Beckwith-Wiedemann Syndrome genetics, Gene Deletion, Genomic Imprinting, Insulin-Like Growth Factor II genetics, Wilms Tumor genetics
- Published
- 2005
- Full Text
- View/download PDF
24. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.
- Author
-
Prawitt D, Enklaar T, Gärtner-Rupprecht B, Spangenberg C, Oswald M, Lausch E, Schmidtke P, Reutzel D, Fees S, Lucito R, Korzon M, Brozek I, Limon J, Housman DE, Pelletier J, and Zabel B
- Subjects
- Base Sequence, CCCTC-Binding Factor, DNA Methylation, Female, Humans, Insulin-Like Growth Factor II genetics, Insulin-Like Growth Factor II metabolism, Male, Pedigree, Beckwith-Wiedemann Syndrome genetics, Chromosomes, Human, Pair 11, DNA-Binding Proteins genetics, Genomic Imprinting, Repressor Proteins genetics, Sequence Deletion, Wilms Tumor genetics
- Abstract
We have analyzed several cases of Beckwith-Wiedemann syndrome (BWS) with Wilms' tumor in a familial setting, which give insight into the complex controls of imprinting and gene expression in the chromosome 11p15 region. We describe a 2.2-kbp microdeletion in the H19/insulin-like growth factor 2 (IGF2)-imprinting center eliminating three target sites of the chromatin insulator protein CTCF that we believe here is necessary, but not sufficient, to cause BWS and Wilms' tumor. Maternal inheritance of the deletion is associated with IGF2 loss of imprinting and up-regulation of IGF2 mRNA. However, in at least one affected family member a second genetic lesion (a duplication of maternal 11p15) was identified and accompanied by a further increase in IGF2 mRNA levels 35-fold higher than control values. Our results suggest that the combined effects of the H19/IGF2-imprinting center microdeletion and 11p15 chromosome duplication were necessary for manifestation of BWS.
- Published
- 2005
- Full Text
- View/download PDF
25. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
- Author
-
Trost TM, Lausch EU, Fees SA, Schmitt S, Enklaar T, Reutzel D, Brixel LR, Schmidtke P, Maringer M, Schiffer IB, Heimerdinger CK, Hengstler JG, Fritz G, Bockamp EO, Prawitt D, Zabel BU, and Spangenberg C
- Subjects
- Breast Neoplasms genetics, Breast Neoplasms metabolism, Cell Cycle physiology, Cell Cycle Proteins genetics, Cell Cycle Proteins metabolism, Cell Line, Tumor, Cell Nucleus metabolism, Cell Transformation, Neoplastic genetics, Cell Transformation, Neoplastic metabolism, Cellular Senescence physiology, Cyclin-Dependent Kinase Inhibitor p21, Gene Expression Regulation, Neoplastic, Humans, Oligonucleotides, Antisense genetics, Oligonucleotides, Antisense pharmacology, Receptor, ErbB-2 biosynthesis, Receptor, ErbB-2 genetics, Signal Transduction, p38 Mitogen-Activated Protein Kinases physiology, Breast Neoplasms pathology, Cell Transformation, Neoplastic pathology, Receptor, ErbB-2 physiology
- Abstract
The receptor tyrosine kinase ERBB2 plays a central role in the development of breast cancer and other epithelial malignancies. Elevated ERBB2 activity is believed to transform cells by transmitting mitogenic and antiapoptotic signals. Here we show that tightly regulated overexpression of oncogenic ERBB2 in human breast carcinoma cells does not stimulate proliferation but provokes premature senescence, accompanied by up-regulation of the cyclin-dependent kinase inhibitor P21(WAF1/CIP1). A similar effect was caused by retrovirus-mediated overexpression of oncogenic ERBB2 in low-passage murine embryonic fibroblasts. In contrast to previous observations based on constitutively overexpressing cell lines, P21 induced by tetracycline-regulated ERBB2 localizes to the nucleus in arrested cells. P21 up-regulation seems to be independent of the P53 tumor suppressor protein, and senescence-associated phenotypic alterations are reversed by specific inhibition of P38 mitogen-activated protein kinases. Functional inactivation of P21 by antisense oligonucleotides is sufficient to prevent cell cycle arrest as well as the senescent phenotype, thereby identifying the P21 protein as the key mediator of hypermitogenic cell cycle arrest and premature senescence in breast carcinoma cells. Our results may thus indicate that premature senescence represents an inherent anticarcinogenic program during ERBB2-driven mammary tumorigenesis. We propose a multistep model for the process of malignant transformation by ERBB2 wherein secondary lesions either target P21 or downstream effectors of senescence to bypass this primary fail-safe mechanism.
- Published
- 2005
26. TRPM5 is a transient Ca2+-activated cation channel responding to rapid changes in [Ca2+]i.
- Author
-
Prawitt D, Monteilh-Zoller MK, Brixel L, Spangenberg C, Zabel B, Fleig A, and Penner R
- Subjects
- Animals, Calcium pharmacology, Calcium Channels physiology, Cations, Cell Line, Cell Membrane metabolism, DNA, Complementary metabolism, Dose-Response Relationship, Drug, Electrophysiology, Humans, Ion Channels metabolism, Islets of Langerhans metabolism, Membrane Proteins metabolism, Patch-Clamp Techniques, Rats, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, TRPM Cation Channels, Taste Buds metabolism, Time Factors, Calcium metabolism, Membrane Proteins physiology, Taste
- Abstract
Transient receptor potential (TRP) proteins are a diverse family of proteins with structural features typical of ion channels. TRPM5, a member of the TRPM subfamily, plays an important role in taste receptors, although its activation mechanism remains controversial and its function in signal transduction is unknown. Here we characterize the functional properties of heterologously expressed human TRPM5 in HEK-293 cells. TRPM5 displays characteristics of a calcium-activated, nonselective cation channel with a unitary conductance of 25 pS. TRPM5 is a monovalent-specific, nonselective cation channel that carries Na+, K+, and Cs+ ions equally well, but not Ca2+ ions. It is directly activated by [Ca2+]i at concentrations of 0.3-1 microM, whereas higher concentrations are inhibitory, resulting in a bell-shaped dose-response curve. It activates and deactivates rapidly even during sustained elevations in [Ca2+]i, thereby inducing a transient membrane depolarization. TRPM5 does not simply mirror levels of [Ca2+]i, but instead responds to the rate of change in [Ca2+]i in that it requires rapid changes in [Ca2+]i to generate significant whole-cell currents, whereas slow elevations in [Ca2+]i to equivalent levels are ineffective. Moreover, we demonstrate that TRPM5 is not limited to taste signal transduction, because we detect the presence of TRPM5 in a variety of tissues and we identify endogenous TRPM5-like currents in a pancreatic beta cell line. TRPM5 can be activated physiologically by inositol 1,4,5-trisphosphate-producing receptor agonists, and it may therefore couple intracellular Ca2+ release to electrical activity and subsequent cellular responses.
- Published
- 2003
- Full Text
- View/download PDF
27. Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.
- Author
-
Schiffer IB, Gebhard S, Heimerdinger CK, Heling A, Hast J, Wollscheid U, Seliger B, Tanner B, Gilbert S, Beckers T, Baasner S, Brenner W, Spangenberg C, Prawitt D, Trost T, Schreiber WG, Zabel B, Thelen M, Lehr HA, Oesch F, and Hengstler JG
- Subjects
- Animals, Cell Cycle physiology, Cell Division physiology, Down-Regulation, Gene Expression Regulation, Neoplastic, Humans, Male, Mice, Mice, Nude, NIH 3T3 Cells, Neoplasms, Experimental genetics, Promoter Regions, Genetic, Receptor, ErbB-2 genetics, Tetracycline pharmacology, Tetracyclines pharmacology, Apoptosis physiology, Neoplasms, Experimental metabolism, Neoplasms, Experimental pathology, Receptor, ErbB-2 antagonists & inhibitors, Receptor, ErbB-2 biosynthesis
- Abstract
Overexpression of the receptor tyrosine kinase HER-2/neu is associated with poor prognosis in patients with breast and ovarian cancer. Recent excitement has surrounded the therapeutic effects of HER-2-blocking therapy strategies and has rekindled interest on the molecular mechanisms of HER-2/neu in tumor biology. To study the role of HER-2/neu overexpression in vivo, we used a murine fibroblast cell line (NIH3T3-her2) conditionally expressing human HER-2/neu under control of a tetracycline-responsive promoter. Expression of HER-2 could be down-regulated below detection limit (>625-fold dilution) by exposure of NIH3T3-her2 cells to anhydrotetracycline (ATc). Subcutaneous injection of NIH3T3-her2 cells into nude mice resulted in rapid tumor growth. Mice with mean tumor volumes of 0.2, 0.8, 1.9, and 14.9 cm(3) were treated daily with 10 mg/kg ATc to switch off HER-2/neu expression, producing reductions in tumor size of 100, 98.1, 81.4, and 74.2%, respectively, by 7 days after onset of ATc administration (P = 0.005, Kruskal-Wallis test). Different long-term effects of HER-2 down-regulation were observed when mice with small (0.2 cm(3); n = 7), intermediate (0.8-1.2 cm(3); n = 10) and large (> or =1.9 cm(3); n = 11) tumors received ATc for up to 40 days. Complete remission was observed for 100, 40, and 18% of the small-, intermediate-, and large-sized tumors, respectively (P = 0.003). However, after 20-45 days of ATc administration, recurrent tumor growth was observed for all mice, even in those with previous complete remissions. The time periods for which mean tumor volume could be suppressed to volumes <0.1 cm(3) under ATc administration were 34, 22, 8, and 0 days for tumors with initial volumes of 0.2, 0.8, 1.9 and 14.9 cm(3), respectively (P = 0.005, Kruskal-Wallis test). Interestingly, HER-2 remained below the detection limit in recurrent tumor tissue, suggesting that initially HER-2-dependent tumors switched to HER-2 independence. The "second hits" leading to HER-2-independent tumor growth have not yet been identified. The rapid regression of tumors after down-regulation of HER-2 was explained by two independent mechanisms: (a) a block in cell cycle progression, as evidenced by a decrease in Ki-67 antigen expression from 40% before ATc treatment to 8.3% after 7 days of ATc treatment; and (b) induction of apoptosis as demonstrated by caspase-3 activation and by the terminal deoxynucleotidyltransferase (Tdt)-mediated nick end labeling assay (TUNEL). In conclusion, we have shown that switching off HER-2 may disturb the sensitive balance between cell proliferation and cell death, leading to apoptosis and tumor remission. Tumor remission was dependent on the volume of the tumors before down-regulation of HER-2/neu.
- Published
- 2003
28. Of mice and models: improved animal models for biomedical research.
- Author
-
Bockamp E, Maringer M, Spangenberg C, Fees S, Fraser S, Eshkind L, Oesch F, and Zabel B
- Subjects
- Animals, Cytochrome P-450 Enzyme System biosynthesis, Cytochrome P-450 Enzyme System genetics, DNA Nucleotidyltransferases genetics, Gene Targeting, Integrases genetics, Isopropyl Thiogalactoside biosynthesis, Isopropyl Thiogalactoside genetics, Mice, Knockout, Mice, Transgenic, Receptors, Steroid genetics, Research, Tetracycline pharmacology, Transcriptional Activation, Viral Proteins genetics, Mice genetics, Models, Animal
- Abstract
The ability to engineer the mouse genome has profoundly transformed biomedical research. During the last decade, conventional transgenic and gene knockout technologies have become invaluable experimental tools for modeling genetic disorders, assigning functions to genes, evaluating drugs and toxins, and by and large helping to answer fundamental questions in basic and applied research. In addition, the growing demand for more sophisticated murine models has also become increasingly evident. Good state-of-principle knowledge about the enormous potential of second-generation conditional mouse technology will be beneficial for any researcher interested in using these experimental tools. In this review we will focus on practice, pivotal principles, and progress in the rapidly expanding area of conditional mouse technology. The review will also present an internet compilation of available tetracycline-inducible mouse models as tools for biomedical research (http://www.zmg.uni-mainz.de/tetmouse/).
- Published
- 2002
- Full Text
- View/download PDF
29. Treatment of a colored groundwater by ozone-biofiltration: pilot studies and modeling interpretation.
- Author
-
Rittmann BE, Stilwell D, Garside JC, Amy GL, Spangenberg C, Kalinsky A, and Akiyoshi E
- Subjects
- Bioreactors, Coloring Agents chemistry, Filtration, Organic Chemicals analysis, Pilot Projects, Silicon Dioxide, Soil Pollutants analysis, Solubility, Oxidants, Photochemical chemistry, Ozone chemistry, Water Purification methods
- Abstract
Pilot studies investigated the fates of color, dissolved organic carbon (DOC), and biodegradable organic matter (BOM) by the tandem of ozone plus biofiltration for treating a source water having significant color (50 cu) and DOC (3.2 mg/l). Transferred ozone doses were from 1.0 to 1.8 g O3/g C. Rapid biofilters used sand, anthracite, or granular activated carbon as media with empty-bed contact time (EBCT) up to 9 min. The pilot studies demonstrated that ozonation plus biofiltration removed most color and substantial DOC, and increasing the transferred ozone dose enhanced the removals. For the highest ozone dose, removals were as high as 90% for color and 38% for DOC. While most of the color removal took place during ozonation, most DOC removal occurred in the biofilters, particularly when the ozone dose was high. Compared to sand and anthracite biofilters, the GAC biofilter gave the best performance for color and DOC removal, but some of this enhanced performance was caused by adsorption, since the GAC was virgin at the beginning of the pilot studies. Backwashing events had no noticeable impact of the performance of the biofilters. The Transient-State, Multiple-Species Biofilm Model (TSMSBM) was used to interpret the experimental results. Model simulations show that soluble microbial products, which comprised a significant part of the effluent BOM, offset the removal of original BOM, a factor that kept the removal of DOC relatively constant over the range of EBCTs of 3.5-9 min. Although improved biofilm retention, represented by a small detachment rate, allowed more total biofilm accumulation and greater removal of original BOM, it also caused more release of soluble microbial products and the build up of inert biomass in the biofilm. Backwashing had little impact on biofilter performance, because it did not remove more than 25% of the biofilm under any condition simulated.
- Published
- 2002
- Full Text
- View/download PDF
30. Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression.
- Author
-
Prawitt D, Enklaar T, Klemm G, Gärtner B, Spangenberg C, Winterpacht A, Higgins M, Pelletier J, and Zabel B
- Subjects
- Adult, Alternative Splicing genetics, Amino Acid Sequence genetics, Base Sequence, Conserved Sequence, Evolution, Molecular, Humans, Infant, Male, Membrane Proteins biosynthesis, Membrane Proteins chemistry, Molecular Sequence Data, RNA, Neoplasm biosynthesis, Rhabdomyosarcoma genetics, TRPM Cation Channels, Transient Receptor Potential Channels, Translocation, Genetic genetics, Tumor Cells, Cultured, Alleles, Beckwith-Wiedemann Syndrome genetics, Calmodulin-Binding Proteins genetics, Chromosomes, Human, Pair 11 genetics, Drosophila Proteins, Genes, Wilms Tumor, Membrane Proteins genetics, Neoplasm Proteins, Sequence Homology, Amino Acid
- Abstract
Alterations within human chromosomal region 11p15.5 are associated with the Beckwith-Wiedemann syndrome (BWS) and predisposition to a variety of neoplasias, including Wilms' tumors (WTs), rhabdoid tumors and rhabdomyosarcomas. To identify candidate genes for 11p15. 5-related diseases we compared human genomic sequence with expressed sequence tag and protein databases from different organisms to discover evolutionarily conserved sequences. Herein we describe the identification and characterization of a novel human transcript related to a putative Caenorhabditis elegans protein and the trp (transient receptor potential) gene. The highest homologies are observed with the human TRPC7 and with melastatin 1 ( MLSN1 ), whose transcript is downregulated in metastatic melanomas. Other genes related to and interacting with the trp family include the Grc gene, which codes for a growth factor-regulated channel protein, and PKD1/PKD2, involved in polycystic kidney disease. The novel gene presented here (named MTR1 for MLSN1 - and TRP -related gene 1) resides between TSSC4 and KvLQT1. MTR1 is expressed as a 4.5 kb transcript in a variety of fetal and adult tissues. The putative open reading frame is encoded in 24 exons, one of which is alternatively spliced leading to two possible proteins of 872 or 1165 amino acids with several predicted membrane-spanning domains in both versions. MTR1 transcripts are present in a large proportion of WTs and rhabdomyosarcomas. RT-PCR analysis of somatic cell hybrids harboring a single human chromosome 11 demonstrated exclusive expression of MTR1 in cell lines carrying a paternal chromosome 11, indicating allele-specific inactivation of the maternal copy by genomic imprinting.
- Published
- 2000
- Full Text
- View/download PDF
31. Hepatitis B virus core promoter mutations in children with multiple anti-HBe/HBeAg reactivations result in enhanced promoter activity.
- Author
-
Gerner P, Lausch E, Friedt M, Tratzmüller R, Spangenberg C, and Wirth S
- Subjects
- Adolescent, Amino Acid Substitution, Base Sequence, Child, DNA, Viral isolation & purification, Hepatitis B e Antigens blood, Hepatitis B, Chronic blood, Humans, Liver virology, Male, Molecular Sequence Data, Polymerase Chain Reaction, Sequence Analysis, DNA, Transcription Factors metabolism, Virus Activation, Virus Integration, Hepatitis B e Antigens immunology, Hepatitis B virus genetics, Hepatitis B, Chronic virology, Mutation, Promoter Regions, Genetic, Viral Core Proteins genetics
- Abstract
Sera of two children were examined to determine whether specific hepatitis B virus (HBV) mutants may contribute to anti-hepatitis B e/hepatitis B e antigen (anti-HBe/HBeAg) reactivations during the course of chronic hepatitis B. The full-length HBV genome isolated from sera of patient 1 and the basic core promoter (BCP) from patient 2 were amplified and sequenced before and after several reactivations. The functional significance of the mutant BCP from patient 1 was studied using the luciferase assay. In both patients, rare mutations were found in the BCP at nucleotides 1764(G-->T)/1766(C-->G) and 1766(C-->T)/1768(T-->A) in case 1 and 2, respectively. In the BCP from patient 1, a putative new binding site for the transcription factor hepatocyte nuclear factor 3 (HNF3) was generated. The functional analyses of the mutant showed a 2.8-fold increase of core promoter activity, whereas the BCP variant of patient 2 was also identified to result in enhanced promoter activity. The alignment of full-length genomes from child 1 to the reference sequence showed 61 nucleotide substitutions. Furthermore, the time of reactivations from child 1 was always accompanied by selection of a precore mutation at nucleotide position 1899. In liver tissue of patient 1 before development of hepatocellular carcinoma only free viral sequences were found, whereas a single site integration of HBV was detected in hepatocytes after activation of carcinogenesis. Specific mutations in the HBV BCP of the two patients that are rarely present in chronic carriers were identified to increase the core promoter activity possibly by altering transcription factor binding, suggesting that these variants may be involved in the pathogenesis of frequent HBV reactivations., (Copyright 1999 Wiley-Liss, Inc.)
- Published
- 1999
- Full Text
- View/download PDF
32. The mouse mammary tumour virus promoter positioned on a tetramer of histones H3 and H4 binds nuclear factor 1 and OTF1.
- Author
-
Spangenberg C, Eisfeld K, Stünkel W, Luger K, Flaus A, Richmond TJ, Truss M, and Beato M
- Subjects
- Adenosine Triphosphatases metabolism, DNA Footprinting, Gene Expression Regulation, HeLa Cells, Histones genetics, Host Cell Factor C1, Humans, Hydroxyl Radical, Molecular Conformation, Molecular Structure, NFI Transcription Factors, Octamer Transcription Factor-1, Protein Binding, Recombinant Proteins metabolism, Transcription, Genetic, DNA-Binding Proteins metabolism, Histones metabolism, Mammary Tumor Virus, Mouse genetics, Nucleosomes metabolism, Promoter Regions, Genetic, Transcription Factors metabolism
- Abstract
Modulation of eukaryotic gene expression is influenced by the organization of regulatory DNA-elements in chromatin. The mouse mammary tumor virus (MMTV) promoter exhibits regularly positioned nucleosomes that reduce the accessibility of the binding sites for sequence-specific transcription factors, in particular nuclear factor (NF1). Hormonal induction of the MMTV promoter is accompanied by remodeling of the nucleosomal structure, but the biochemical nature of these structural changes is unknown. Using recombinant histones, we have now assembled the MMTV promoter in particles containing either an octamer of the histones H3, H4, H2A and H2B or a tetramer of histones H3 and H4, and have compared the two particles in terms of structure, positioning, and exclusion of transcription factors. Using site-directed hydroxy radicals to map histone locations, two main nucleosome positions are found with dyads at position -107 and at -127. The same two main positions are found for particles containing only the H3/H4 tetramer, showing that the absence of H2A/H2B dimers does not alter positioning. The rotational orientation of the DNA double helix in both types of particles is essentially identical. However, the ends of the nucleosomal DNA as well as its central region are more accessible to cleavage reagents in the tetramer particle than in the octamer particle. In agreement with these structural features, the transcription factors NF1 and OTF1 were able to bind to their cognate sites on the tetramer particle, while they could not gain access to the same sites on the surface of the octamer particle. The DNase I digestion pattern of octamers treated with partially purified SWI/SNF complex from HeLa cells in the presence of ATP is indistinguishable from that of tetramer particles, suggesting that the SWI/SNF complex promotes ATP-dependent remodeling of the octamer particle but not of tetramer particles. These results are compatible with a hormone-induced removal of histone H2A/H2B during MMTV induction.
- Published
- 1998
- Full Text
- View/download PDF
33. Structural and functional implications of sequence diversity of Pseudomonas aeruginosa genes oriC, ampC and fliC.
- Author
-
Spangenberg C, Montie TC, and Tümmler B
- Subjects
- Base Sequence, DNA, Bacterial, Genes, Bacterial, Molecular Sequence Data, Sequence Analysis, DNA, Sequence Homology, Nucleic Acid, Bacterial Proteins, Flagellin genetics, Genetic Variation, Pseudomonas aeruginosa genetics, Replication Origin, beta-Lactamases genetics
- Abstract
Sequence analysis of three representative gene loci, oriC, ampC and fliC, in 19 Pseudomonas aeruginosa strains revealed a low sequence diversity that does not correlate with the extensive diversity of P. aeruginosa habitats. Single point mutations lead to a mean sequence diversity of 0.40%, 0.38% and 0.59% for oriC, ampC and a-type fliC, respectively, but of only 0.05% for b-type flagellin genes. The analyzed genes encode highly conserved functions that are subject to strong selective pressure. The detected nucleotide substitutions of oriC, accumulating in a central 95 bp region, affect neither the putative DnaA binding sites nor the 13 bp direct repeats that presumably provide the sites to open oriC duplex DNA. Even in P. aeruginosa strain DSM 1128, which exhibits an unusually high sequence variability in several analyzed genes, the 9 bp and 13 bp motifs are conserved, reflecting their essential functional role in replication initiation. The two flagellin types, differing by 37-38% in their primary structure, exhibit pronounced structural and functional homology, as shown by alignment of flagellin variants by hydrophobicity index, probability of surface exposure, chain flexibility and antigenicity, and by cross-reactivity between both proteins using specific antisera. Five nonsynonymous nucleotide substitutions of ampC lead to beta-lactamase variants that differ in recognition and turnover of substrate, as deduced from the three-dimensional structure of the highly homologous Enterobacter cloacae beta-lactamase and confirmed by inhibition kinetics. The identified point mutations in the three genes are classified as selectively equivalent sequence variants indicating neutral genetic drift as a mechanism of molecular evolution in P. aeruginosa, rather than positive selection.
- Published
- 1998
- Full Text
- View/download PDF
34. Cloning and characterization of a novel gene (TM7SF1) encoding a putative seven-pass transmembrane protein that is upregulated during kidney development.
- Author
-
Spangenberg C, Winterpacht A, Zabel BU, and Löbbert RW
- Subjects
- Adult, Blotting, Northern, Chromosome Mapping, Chromosomes, Human, Pair 1 genetics, Cloning, Molecular, DNA, Complementary isolation & purification, Fetus, GTP-Binding Proteins biosynthesis, GTP-Binding Proteins genetics, GTP-Binding Proteins isolation & purification, Humans, Kidney embryology, Membrane Proteins biosynthesis, Membrane Proteins isolation & purification, Molecular Sequence Data, Receptors, G-Protein-Coupled, Sequence Analysis, DNA, Gene Expression Regulation, Developmental genetics, Kidney growth & development, Kidney metabolism, Membrane Proteins genetics, Up-Regulation genetics
- Abstract
We have used the cDNA differential display of mRNA technique to isolate genes differentially regulated during kidney development. Here we report the identification of a novel gene, TM7SF1, which is upregulated in the course of kidney development. The full-length cDNA of TM7SF1 is about 2.4 kb and contains an open reading frame of 1197 nucleotides. The predicted secondary structure of the corresponding protein displays seven putative helical transmembrane domains, a structural feature shared by all members of the G-protein-coupled receptor class of transmembrane proteins. Two minor alternatively spliced versions of approximately 2.3 and approximately 2.2 kb could be detected, one of which contains a nearly identical open reading frame with a truncated carboxy-terminus of the deduced protein. The second alternatively spliced version harbors a completely shifted open reading frame with a potential new ATG start codon. By the use of single-chromosome hybrid cells and fluorescence in situ hybridization experiments, TM7SF1 could be localized to chromosome 1q42-q43. Human multiple tissue Northern blot analysis revealed TM7SF1 transcripts in human kidney, heart, brain, and placenta tissue. Studies on Wilms tumor samples showed variable TM7SF1 expression, ranging from nearly undetectable levels to an abundant level of expression comparable to that of adult kidney tissue.
- Published
- 1998
- Full Text
- View/download PDF
35. Disrespectful type IV pilins.
- Author
-
Spangenberg C, Fislage R, Römling U, and Tümmler B
- Subjects
- Bacterial Proteins classification, DNA, Bacterial analysis, Fimbriae Proteins, GC Rich Sequence, Membrane Proteins classification, Phylogeny, Bacterial Proteins genetics, Membrane Proteins genetics
- Published
- 1997
36. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
- Author
-
Tümmler B, Bosshammer J, Breitenstein S, Brockhausen I, Gudowius P, Herrmann C, Herrmann S, Heuer T, Kubesch P, Mekus F, Römling U, Schmidt KD, Spangenberg C, and Walter S
- Subjects
- Cystic Fibrosis complications, Cystic Fibrosis immunology, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Disease Susceptibility, Humans, Lung microbiology, Phenotype, Pseudomonas Infections etiology, Pseudomonas Infections immunology, Pseudomonas aeruginosa isolation & purification, Cystic Fibrosis microbiology, Lung Diseases microbiology, Pseudomonas Infections epidemiology, Pseudomonas aeruginosa genetics
- Abstract
The lung infection with Pseudomonas aeruginosa is regarded as one of the major causes of health decline in patients with cystic fibrosis (CF). The CF host response to the persistent bacterial antigen load in the endobronchiolar lumen is characterized by a pronounced humoral response, local production of cytokines, influx of neutrophils into the lung and a protease-protease inhibitor imbalance predominantly sustained by released neutrophil elastase. CF is an autosomal recessive disease, and we could demonstrate for our local patient population that the age-dependent risk to become chronically colonized with P. aeruginosa can be differentiated by the disease-causing CFTR mutation genotype. The age-specific colonisation rates were significantly lower in pancreas sufficient than in pancreas insufficient patients. P. aeruginosa is occasionally detected in throat swabs already in infancy or early childhood in most patients although there is a lapse of several years amenable to preventive measures such as vaccination until onset of persistent colonization. The epidemiology of the infection with P. aeruginosa was investigated by quantitative macrorestriction fragment pattern analysis. The distribution and frequency of clones found in CF patients match that found in other clinical and environmental aquatic habitats, but the over-representation of specific clones at a CF clinic indicates a significant impact of nosocomial transmission for the prevalence of P. aeruginosa-positive patients at a particular center. Most patients remain colonized with the initially acquired P. aeruginosa clone. According to direct sputum analysis the majority of patients is carrying a single clonal variant at a concentration of 10(7)-10(9) CFU. Co-colonization with other species or other clones is infrequent. Independent of the underlying genotype, the CF lung habitat triggers a uniform, genetically fixed conversion of bacterial phenotype. Most CFP, aeruginosa strains become non-motile, mucoid, LPS-, pyocin- and phage-deficient, secrete less virulence determinants and shift the production of cytokines evoked in neutrophils. On the other hand, other properties such as antimicrobial susceptibility or adherence to bronchial mucins remain highly variable reflecting the capacity of P. aeruginosa to adapt to ongoing changes in the CF lung habitat.
- Published
- 1997
37. Genetic diversity of flagellins of Pseudomonas aeruginosa.
- Author
-
Spangenberg C, Heuer T, Bürger C, and Tümmler B
- Subjects
- Amino Acid Sequence, Bacterial Outer Membrane Proteins chemistry, Bacterial Outer Membrane Proteins genetics, Base Sequence, Chromosome Mapping, Chromosomes, Bacterial, Cloning, Molecular, Conserved Sequence, Fimbriae Proteins, Flagellin chemistry, Genes, Bacterial, Molecular Sequence Data, Phenotype, Pseudomonas aeruginosa chemistry, Sequence Analysis, DNA, Flagellin genetics, Genetic Variation, Pseudomonas aeruginosa genetics
- Abstract
Physical genome analysis of the virulence-associated fliC locus in 20 Pseudomonas aeruginosa strains by mapping and sequencing revealed groups of heterologous a-type (1164 bp; 1185 bp) and highly conserved b-type (1467 bp) flagellin genes. Whereas only two synonymous nucleotide substitutions were detected in eight b-type fliC sequences, the 12 a-type sequences exhibited 57 nucleotide substitutions, of which 39 occurred within a variable central region. Although a-type and b-type flagellins differ by 35% in their primary structure, they share strong homology in their predicted features, implying that the polymorphic proteins fold into similar structures during polymerization of the flagella.
- Published
- 1996
- Full Text
- View/download PDF
38. [Colon sonography. A new procedure of colon imaging].
- Author
-
Löhr KL and Spangenberg C
- Subjects
- Colonic Neoplasms diagnosis, Diagnosis, Differential, Humans, Intestinal Polyps diagnosis, Colonic Diseases diagnosis, Ultrasonography
- Published
- 1982
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.